China Sky One nasal spray for rheumatic disease

China Sky One Medical, a fully-integrated pharmaceutical company producing external use, over-the-counter drugs in China, say that it has successfully developed a nasal spray for the treatment and prevention of rheumatic disease.

Heilongjiang Tianlong Pharmaceutical, a wholly-owned subsidiary of China Sky One, recently completed R&D for the spray, which includes the active ingredients naphazoline HCl, chlorpheniramine maleate and benzalkonium bromide. Rheumatic diseases are shown in common sympathies and characterized by joint inflammation. There are currently only five other manufacturers of the spray in China and China Sky One has obtained the necessary approvals for production.